Metraipolis › archive › dc_efcb90222f1a

Feasibility of Therapist-Driven MR-Guided Adaptive Radiotherapy for Oligometastatic Disease: Geometric Accuracy and Dosimetric Impact — Europe PMC PMID:40856404

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40856404
DOI
10.1111/1754-9485.70016
License (as archived)
solo-consultazione
Archived
2026-11-10T08:04:59.649Z
SHA-256 of the archived text
15c2712a1d2e55b1c63d89a7b724bebab8ef3fc21a9fe2bd5ba11d9ac1342589
Stable URL of this page
https://metraipolis.com/documento/dc_efcb90222f1a

How to cite

Feasibility of Therapist-Driven MR-Guided Adaptive Radiotherapy for Oligometastatic Disease: Geometric Accuracy and Dosimetric Impact — Europe PMC PMID:40856404 — Europe PMC (en), https://europepmc.org/article/MED/40856404 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efcb90222f1a (Metraipolis archive dc_efcb90222f1a, sha256 15c2712a1d2e55b1c63d89a7b724bebab8ef3fc21a9fe2bd5ba11d9ac1342589)
BibTeX
@misc{dcefcb90222f1a,
  title = {Feasibility of Therapist-Driven MR-Guided Adaptive Radiotherapy for Oligometastatic Disease: Geometric Accuracy and Dosimetric Impact — Europe PMC PMID:40856404},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40856404},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efcb90222f1a; sha256 15c2712a1d2e55b1c63d89a7b724bebab8ef3fc21a9fe2bd5ba11d9ac1342589},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40856404. Agents can read the archived copy with the MCP tool read_document.